Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma ; volume:164 ; number:2 ; day:4 ; month:9 ; year:2023 ; pages:331-339 ; date:9.2023
Journal of neuro-oncology ; 164, Heft 2 (4.9.2023), 331-339, 9.2023
- Creator
-
Minniti, Giuseppe
Paolini, Sergio
Antonelli, Manila
Gianno, Francesca
Tini, Paolo
Lanzetta, Gaetano
Arcella, Antonella
Pietro, Raffaella De
Giraffa, Martina
Capone, Luca
Romano, Andrea
Bozzao, Alessandro
Esposito, Vincenzo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-023-04418-z
- URN
-
urn:nbn:de:101:1-2023121313544212648769
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Minniti, Giuseppe
- Paolini, Sergio
- Antonelli, Manila
- Gianno, Francesca
- Tini, Paolo
- Lanzetta, Gaetano
- Arcella, Antonella
- Pietro, Raffaella De
- Giraffa, Martina
- Capone, Luca
- Romano, Andrea
- Bozzao, Alessandro
- Esposito, Vincenzo
- SpringerLink (Online service)
Other Objects (12)
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
5-Aminolevulinic acid a biomarker for worse prognosis in IDH-wildtype brain tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: Case Report
Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
5-Aminolevulinic acid a biomarker for worse prognosis in IDH-wildtype brain tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: Case Report
Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting
Unusual Extra-Axial and Extracranial Recurrence in an IDH Mutant Astrocytoma: A Case Report
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3
Genetically engineered murine NSCs mimic human IDH-mut astrocytoma
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis
Molecular Landscape for Malignant Transformation in Diffuse Astrocytoma
Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
5-Aminolevulinic acid a biomarker for worse prognosis in IDH-wildtype brain tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: Case Report
Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting